3 unknown. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 1 | 1 | Unknown 1 |
Follow Antineoplastic Agents: new trials by email Literature Review of Antineoplastic Agents trials Research Report on Antineoplastic Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC Carrelizumab, Pemetrexed (Nonsquamous NSCLC) or Nab-paclitaxel(Squamous NSCLC), Carboplatin - Non Small Cell Lung Cancer | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 30 | 2021-08-20 | 2021-09-02 |
| A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients Plasma soluble TNF receptor pulldown, Plasma soluble TNF receptor pulldown + chemotherapy, Chemotherapy Drugs, Cancer - Advanced Breast Cancer | Phase 1 / Phase 2 | Unknown | Immunicom Inc | 170 | 2019-05-31 | 2022-03-24 |
| Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer Bevacizumab - Advanced Ovarian Cancer | Phase 2 | Unknown | Nada Hassan Salah | 40 | 2018-09-01 | 2018-08-02 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1)
Immunicom Inc (1) · Nada Hassan Salah (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
China (1) · Poland (1) · Turkey (Türkiye) (1)
Adam Ostrowski, MD (1) · Yongde Liao, PhD (1)